Home/Oxford Biomedica/Namrata P Patel
NP

Namrata P Patel

Independent Non-Executive Director

Oxford Biomedica

Oxford Biomedica Pipeline

DrugIndicationPhase
Kymriah (Novartis) - LV Vector SupplyB-cell Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-Cell Lymphoma (DLBCL)Approved